Evidence map›Paper›PMID 32932631›Full record

ArticleJournal of clinical medicine2020

Long-Term Safety of Endoscopic Biliary Stents for Cholangitis Complicating Choledocholithiasis: A Multi-Center Study.

Wisam Sbeit, Tawfik Khoury, Anas Kadah, Dan M Livovsky, Adi Nubani, Amir Mari, Eran Goldin, Mahmud Mahamid

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wisam SbeitDepartment of Gastroenterology, Galilee Medical Center, Nahariya 2221006, Israel.
Tawfik KhouryDepartment of Gastroenterology, Galilee Medical Center, Nahariya 2221006, Israel.ORCID 0000-0001-6699-8625
Anas KadahDepartment of Gastroenterology, Galilee Medical Center, Nahariya 2221006, Israel.ORCID 0000-0002-4738-3390
Dan M LivovskyGastroenterology Department, Sha'arei Zedek Medical Center, Jerusalem 9103102, Israel.
Adi NubaniGastroenterology Department, Sha'arei Zedek Medical Center, Jerusalem 9103102, Israel.ORCID 0000-0001-9163-0697
Amir MariFaculty of Medicine in the Galilee, Bar-Ilan University, Safed 13100, Israel.
Eran GoldinGastroenterology Department, Sha'arei Zedek Medical Center, Jerusalem 9103102, Israel.
Mahmud MahamidGastroenterology Department, Sha'arei Zedek Medical Center, Jerusalem 9103102, Israel.
Bar-Ilan University · ILHebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTreatment of cholangitis complicating choledocholithiasis includes biliary sphincterotomy and stone extraction. In certain cases of elderly comorbid patients with high risk for definitive endoscopic treatment, biliary stenting is the only measure for relieving biliary obstruction.

aimWe aimed to report the safety of retained biliary stone.

methodsa multi-center, retrospective case-control study conducted at two Israeli medical centers from January 2013 to December 2018 including all patients 18 years of age or older who underwent ERCP and biliary stent insertion for the treatment of acute cholangitis due to choledocholithiasis.

resultsThree-hundred and eight patients were identified. Eighty-three patients had retained long-term biliary stents of more than 6 months (group A) from insertion compared to 225 patients whose biliary stents were removed within a 6-month period (group B). The mean follow-up in group A was 66.1± 16.3 vs. 11.1 ± 2.7 weeks in group B. Overall complications during the follow-up were similar between groups A and B (6% vs. 4.9%, OR 1.24, Chi square 0.69). Similarly, the rate of each complication alone was not different when comparing group A to group B (3.6%, 1.2% and 1.2% vs. 2.7%, 0.44% and 1.8%) for cholangitis, stent related pancreatitis and biliary colic, respectively (Chi square 0.85). Even after 12 months, the rates of overall complications and each complication alone were not higher compared to less than 12 months (Chi square 0.72 and 0.8, respectively).

conclusionendoscopic biliary stenting for cholangitis complicating choledocholithiasis is safe for the long-term period without increase in stent related complications.

Indexed as

biliarycholangitislong-termsafetystents

Identifiers

PMID32932631
PMCPMC7564722
OpenAlexW3085641825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.